Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    Open Studies | "Condylomata Acuminata"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Condylomata Acuminata"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs)
Conditions: Condyloma Acuminata;   Genital Warts;   Condylomata Acuminata;   Venereal Warts
Interventions: Drug: Vehicle gel;   Drug: SR-T100 gel with 1.0 % SM;   Drug: SR-T100 gel with 2.3% SM
2 Recruiting Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma
Condition: Condylomata Acuminata
Interventions: Device: Carbon dioxide Laser ablation;   Device: Electrocoagulation
3 Unknown  Epidemiology, Costs and Psychosocial Consequences of Genital Warts in Valparaiso, Chile
Condition: Condylomata Acuminata
4 Recruiting Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts
Condition: Condylomata Acuminata (External)
Interventions: Drug: Omiganan (CLS001) topical gel;   Drug: Vehicle topical gel
5 Not yet recruiting Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine
Condition: Condylomata Acuminata
Interventions: Biological: low dosage HPV Vaccine(1:1);   Biological: low dosage HPV Vaccine(1:2);   Biological: high dosage HPV Vaccine(1:1);   Biological: Hepatitis E vaccine,Hecolin®
6 Recruiting Safety and Efficacy Double Blind Vehicle Controlled Study of 15% AS101 Gel to Treat External Genital Warts
Condition: External Genital Warts
Interventions: Drug: 15% AS101 gel;   Drug: Vehicle
7 Not yet recruiting Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts
Condition: Genital Warts
Interventions: Biological: Quadrivalent HPV vaccine;   Biological: Hepatitis B vaccine
8 Recruiting A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients
Condition: Condyloma
Interventions: Drug: AP611074 5% gel;   Drug: AP611074 matching placebo
9 Unknown  A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts
Conditions: Genital Warts;   HPV
Interventions: Drug: Oral Zinc;   Drug: Placebo

Indicates status has not been verified in more than two years